Hsbc Holdings PLC Arrowhead Pharmaceuticals, Inc. Transaction History

Hsbc Holdings PLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$27.21 - $39.48 $259,066 - $375,889	9,521 New	9,521 $272,000
Q3 2021 Nov 12, 2021	SELL	$58.38 - $84.96 $334,050 - $486,141	-5,722 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$62.15 - $90.32 $355,622 - $516,811	5,722 New	5,722 $473,000
Q1 2021 May 14, 2021	SELL	$61.35 - $90.47 $556,935 - $821,286	-9,078 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$43.82 - $85.37 $397,797 - $774,988	9,078 New	9,078 $696,000
Q3 2020 Nov 12, 2020	SELL	$33.21 - $51.27 $156,651 - $241,840	-4,717 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$26.12 - $43.27 $123,208 - $204,104	4,717 New	4,717 $204,000
Q1 2020 May 15, 2020	SELL	$20.56 - $63.12 $175,500 - $538,792	-8,536 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$28.14 - $73.01 $8,807 - $22,852	-313 Reduced 3.54%	8,536 $549,000
Q3 2019 Nov 14, 2019	BUY	$26.26 - $34.86 $232,374 - $308,476	8,849 New	8,849 $249,000
Q2 2019 Aug 13, 2019	SELL	$17.43 - $28.82 $827,855 - $1.37 Million	-47,496 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$12.05 - $20.18 $2.31 Million - $3.86 Million	-191,432 Reduced 80.12%	47,496 $872,000
Q4 2018 Feb 13, 2019	BUY	$10.74 - $19.7 $2.57 Million - $4.71 Million	238,928 New	238,928 $2.97 Million

296

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.97B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.